查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1322268

肌萎縮側索硬化症治療市場（類型：散發性 ALS 和家族性 ALS；治療：藥物、幹細胞治療等）- 全球行業分析、規模、佔有率、成長、趨勢和預測，2023-2031 年

Amyotrophic Lateral Sclerosis Treatment Market (Type: Sporadic ALS and Familial ALS; Treatment: Medication, Stem Cell Therapy, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 195 Pages | 商品交期: 2-10個工作天內

價格

肌萎縮側索硬化症治療市場 - 報告範圍

TMR 關於全球肌萎縮側索硬化症治療市場的報告研究了過去以及當前的成長趨勢和機會，以獲得2023 年至2031 年預測期內市場指標的寶貴見解。該報告提供了全球肌萎縮側索硬化症治療市場的收入2017-2031 年硬化症治療市場，以 2023 年為基準年，2031 年為預測年。該報告還提供了2023年至2031年全球肌萎縮側索硬化症治療市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領袖和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解肌萎縮側索硬化症治療市場。

該報告深入研究了全球肌萎縮側索硬化症治療市場的競爭格局。全球肌萎縮側索硬化症治療市場的主要參與者已經確定，並且每一位參與者都根據各種屬性進行了分析。公司概述、財務狀況、最新發展和 SWOT 是本報告中介紹的全球肌萎縮側索硬化症治療市場參與者的屬性。

目錄

第一章：前言

第 2 章：假設和研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 按地區/全球划分的監管情景
  • 管道分析
  • 定價分析
  • COVID-19 大流行對行業的影響

第 6 章：全球市場分析與預測：按類型

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按類型，2017-2031
    • 散發性肌萎縮側索硬化症
    • 家族性肌萎縮側索硬化症
  • 市場吸引力分析：按類型

第 7 章：全球市場分析與預測：按處理方式

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按處理方式，2017-2031
    • 藥物
    • 幹細胞治療
    • 其他
  • 市場吸引力分析：按處理方式

第 8 章：全球市場分析與預測：按配銷通路

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：2017-2031年按配銷通路
    • 醫院藥房
    • 零售藥店
    • 其他
  • 市場吸引力分析：按配銷通路

第 9 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第 10 章：北美市場分析與預測

第 11 章：歐洲市場分析與預測

第 12 章：亞太市場分析與預測

第 13 章：拉丁美洲市場分析與預測

第 14 章：中東和非洲市場分析與預測

第 15 章：競爭格局

  • 市場參與者 - 競爭矩陣（按公司層級和規模）
  • 市場佔有率分析：按公司分類，2022 年
  • 公司簡介
    • Mitsubishi Tanabe Pharma Corporation
    • Otsuka Pharmaceutical Co., Ltd.
    • BrainStorm Therapeutics
    • Biogen, Inc.
    • Corestem
    • AB Science
    • F. Hoffmann-La Roche AG
    • Biohaven Pharmaceutical
    • Sun Pharmaceutical
    • Other Prominent Players
Product Code: TMRGL65843

Amyotrophic Lateral Sclerosis Treatment Market - Scope of Report

TMR's report on the global Amyotrophic Lateral Sclerosis Treatment Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Amyotrophic Lateral Sclerosis Treatment Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Amyotrophic Lateral Sclerosis Treatment Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Amyotrophic Lateral Sclerosis Treatment Market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Amyotrophic Lateral Sclerosis Treatment Market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Amyotrophic Lateral Sclerosis Treatment Market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Amyotrophic Lateral Sclerosis Treatment Market.

The report delves into the competitive landscape of the global Amyotrophic Lateral Sclerosis Treatment Market. Key players operating in the global Amyotrophic Lateral Sclerosis Treatment Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Amyotrophic Lateral Sclerosis Treatment Market profiled in this report.

Key Questions Answered in Global Amyotrophic Lateral Sclerosis Treatment Market Report:

  • What is the sales/revenue generated by mobile photo printer across all regions during the forecast period?
  • What are the opportunities in the global Amyotrophic Lateral Sclerosis Treatment Market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Amyotrophic Lateral Sclerosis Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global Amyotrophic Lateral Sclerosis Treatment Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Amyotrophic Lateral Sclerosis Treatment Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Amyotrophic Lateral Sclerosis Treatment.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Amyotrophic Lateral Sclerosis Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Amyotrophic Lateral Sclerosis Treatment Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Regulatory Scenario by Region/globally
  • 5.2. Pipeline Analysis
  • 5.3. Pricing Analysis
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Amyotrophic Lateral Sclerosis Treatment Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Type, 2017-2031
    • 6.3.1. Sporadic ALS
    • 6.3.2. Familial ALS
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Amyotrophic Lateral Sclerosis Treatment Market Analysis and Forecast, by Treatment

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Treatment, 2017-2031
    • 7.3.1. Medication
    • 7.3.2. Stem Cell Therapy
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by Treatment

8. Global Amyotrophic Lateral Sclerosis Treatment Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Amyotrophic Lateral Sclerosis Treatment Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Amyotrophic Lateral Sclerosis Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Type, 2017-2031
    • 10.2.1. Sporadic ALS
    • 10.2.2. Familial ALS
  • 10.3. Market Value Forecast, by Treatment, 2017-2031
    • 10.3.1. Medication
    • 10.3.2. Stem Cell Therapy
    • 10.3.3. Others
  • 10.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Treatment
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Amyotrophic Lateral Sclerosis Treatment Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Type, 2017-2031
    • 11.2.1. Sporadic ALS
    • 11.2.2. Familial ALS
  • 11.3. Market Value Forecast, by Treatment, 2017-2031
    • 11.3.1. Medication
    • 11.3.2. Stem Cell Therapy
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Treatment
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2017-2031
    • 12.2.1. Sporadic ALS
    • 12.2.2. Familial ALS
  • 12.3. Market Value Forecast, by Treatment, 2017-2031
    • 12.3.1. Medication
    • 12.3.2. Stem Cell Therapy
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Treatment
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Latin America Amyotrophic Lateral Sclerosis Treatment Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2017-2031
    • 13.2.1. Sporadic ALS
    • 13.2.2. Familial ALS
  • 13.3. Market Value Forecast, by Treatment, 2017-2031
    • 13.3.1. Medication
    • 13.3.2. Stem Cell Therapy
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By Treatment
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type, 2017-2031
    • 14.2.1. Sporadic ALS
    • 14.2.2. Familial ALS
  • 14.3. Market Value Forecast, by Treatment, 2017-2031
    • 14.3.1. Medication
    • 14.3.2. Stem Cell Therapy
    • 14.3.3. Others
  • 14.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Type
    • 14.6.2. By Treatment
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2022
  • 15.3. Company Profiles
    • 15.3.1. Mitsubishi Tanabe Pharma Corporation
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Otsuka Pharmaceutical Co., Ltd.
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. BrainStorm Therapeutics
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Biogen, Inc.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Corestem
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. AB Science
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. F. Hoffmann-La Roche AG
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Biohaven Pharmaceutical
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Sun Pharmaceutical
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Other Prominent Players

List of Tables

  • Table 01: Global Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 02: Global Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 03: Global Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 04: Global Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 06: North America Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 07: North America Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 08: North America Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 09: Europe Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 10: Europe Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 11: Europe Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 12: Europe Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 13: Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 14: Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 15: Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 16: Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Latin America Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 18: Latin America Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 19: Latin America Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 20: Latin America Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 21: Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 22: Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 23: Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 24: Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

List of Figures

  • Figure 01: Global Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 03: Global Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 04: Global Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Treatment, 2022 and 2031
  • Figure 05: Global Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 06: Global Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 07: Global Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 08: Global Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 09: Global Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 10: North America Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 11: North America Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 12: North America Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 13: North America Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Treatment, 2022 and 2031
  • Figure 14: North America Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 15: North America Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 16: North America Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 17: North America Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 18: North America Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 19: Europe Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 20: Europe Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 21: Europe Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 22: Europe Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Treatment, 2022 and 2031
  • Figure 23: Europe Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 24: Europe Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 25: Europe Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 26: Europe Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 27: Europe Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 28: Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 29: Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 30: Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 31: Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Treatment, 2022 and 2031
  • Figure 32: Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 33: Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 34: Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 35: Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 36: Asia Pacific Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 37: Latin America Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 38: Latin America Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 39: Latin America Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 40: Latin America Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Treatment, 2022 and 2031
  • Figure 41: Latin America Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 42: Latin America Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 43: Latin America Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 44: Latin America Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 45: Latin America Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 46: Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 47: Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 48: Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 49: Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Treatment, 2022 and 2031
  • Figure 50: Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 51: Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 52: Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 53: Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 54: Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 55: Global Amyotrophic Lateral Sclerosis Treatment Market Share Analysis, by Company, 2022